Table 4 Delayed increase in peripheral blood cell counts for acute myeloid leukemia (AML) patients with stable disease during treatment with all-trans retinoic acid (ATRA), valproic acid and low-dose cytarabine; a comparison of pretreatment/early treatment values versus maximal levels
| Â | Platelet | Neutrophil | Erythrocyte | ||
|---|---|---|---|---|---|
Patient | Before or during the first 14 days | Highest value during treatment | Before or during the first 14 days | Highest value during treatment | Transfusion independent > two months |
SD1 | 12 | 49 (90) | 0.1 | 0.7 (102) | yes |
SD2 | 22 | 64 (273) | 0.1 | 0.8 (77) | yes |
SD3 | < 5 | 79 (55) | 0.4 | 0.4 (74) | - |
SD4 | 103 | 302 (51) | 0.5 | 0.2 (126) | - |
SD5 | 19 | 51 (136) | < 0.1 | 0.3 (67) | yes |
SD6 | 55 | 81 (106) | < 0.1 | 0.2 (112) | - |
SD7 | 18 | 30 (15) | 9.8 | 7.2 (27) | - |
SD8 | 48 | 98 (40) | 3.8 | 8.2 (473) | - |
SD9 | 28 | 96 (141) | 2.9 | 1.8 (49) | - |